Xaser94
Established Member
- Reaction score
- 661
https://www.sharesmagazine.co.uk/news/market/5644131/PureTech-Health-plc-Half-year-Report
The only significant information I had really seen is the following:
"Additional progress has also been made toward the initiation of the Follica RAIN pivotal study in androgenetic alopecia as well as the identification and testing of next-generation, proprietary compounds based on the Group's intellectual property. The Follica RAIN pivotal study is expected to commence in the first half of 2018, following the completion of an optimisation study that is expected to begin imminently."
So it seems like follica is definitely testing next generation compounds as they put it. The unfortunate news is their pivotal trial is now pushed back until first half of 2018. This is bad news but the good news is that their optimization study is expected to begin imminently (which reads as soon, but closer to now). I believe the original plan was that the optimization study led into their pivotal trial. Which means if they did 3 months for their optimization trial, their pivotal trial was only gonna last 9 months if successful. Maybe @Noisette cam confirm that?
Overall this isn't good news. Not terrible news, but def not the good news I was hoping for. I am going to start microdosing finasteride (.5 mg), and hope I can maintain and not get sides. I def can't wait any longer.
The only significant information I had really seen is the following:
"Additional progress has also been made toward the initiation of the Follica RAIN pivotal study in androgenetic alopecia as well as the identification and testing of next-generation, proprietary compounds based on the Group's intellectual property. The Follica RAIN pivotal study is expected to commence in the first half of 2018, following the completion of an optimisation study that is expected to begin imminently."
So it seems like follica is definitely testing next generation compounds as they put it. The unfortunate news is their pivotal trial is now pushed back until first half of 2018. This is bad news but the good news is that their optimization study is expected to begin imminently (which reads as soon, but closer to now). I believe the original plan was that the optimization study led into their pivotal trial. Which means if they did 3 months for their optimization trial, their pivotal trial was only gonna last 9 months if successful. Maybe @Noisette cam confirm that?
Overall this isn't good news. Not terrible news, but def not the good news I was hoping for. I am going to start microdosing finasteride (.5 mg), and hope I can maintain and not get sides. I def can't wait any longer.
